Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACTR202007634121137Not yet recruiting
Trial of magnesium sulfate and levobupivacaine in Not applicable (2 arms), sponsored by Dr Tamer Mohamed Naguib. Primary endpoint: onset of the block. Planned start Aug 2020; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on PACTR202007634121137.